(19)
(11) EP 1 220 895 A1

(12)

(43) Date of publication:
10.07.2002 Bulletin 2002/28

(21) Application number: 00969592.5

(22) Date of filing: 13.10.2000
(51) International Patent Classification (IPC)7: C12N 9/10, C07K 14/435, A61K 38/45, A61K 48/00, C12Q 1/68, G01N 33/68
(86) International application number:
PCT/FI0000/891
(87) International publication number:
WO 0127/249 (19.04.2001 Gazette 2001/16)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 15.10.1999 US 159762 P

(71) Applicants:
  • Finnish Immunotechnology Ltd.
    33520 Tampere (FI)
  • Krohn, Kai
    36450 Salmentaka (FI)
  • Aapola, Ulla
    33720 Tampere (FI)
  • Scott, Hamish
    Melbourne,Australian Capital Territory 3050 (AU)
  • Antonarakis, Stylianos
    1205 Geneva (CH)
  • Shimizu, Nobuyoshi
    Sakura-shi,Chiba-ken 285-0858 (JP)

(72) Inventors:
  • KROHN, Kai
    FIN-36450 Salmentaka (FI)
  • AAPOLA, Ulla
    FIN-33720 Tampere (FI)
  • SCOTT, Hamish,Walter and Eliza Hall
    Melbourne, ACT 3050 (AU)
  • ANTONARAKIS, Stylianos
    CH-1205 Geneva (CH)
  • SHIMIZU, Nobuyoshi
    Sakura,Chiba 285 (JP)
  • KUDOH, Jun
    Tokyo 113 (JP)
  • PETERSON, Pärt
    FIN-33540 Tampere (FI)

(74) Representative: Halmepuro, Liisa 
Kolster Oy AbIso Roobertinkatu 23P.O. Box 148
FIN-00121 Helsinki
FIN-00121 Helsinki (FI)

   


(54) NOVEL GENE ENCODING A DNA METHYLTRANSFERASE, DNMT3L